Evidence map›Paper›PMID 35743693›Full record

ArticleJournal of personalized medicine2022

Transparent Quality Optimization for Machine Learning-Based Regression in Neurology.

Karsten Wendt, Katrin Trentzsch, Rocco Haase, Marie Luise Weidemann, Robin Weidemann, Uwe Aßmann, Tjalf Ziemssen

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karsten WendtSoftware Technology Group, Technische Universität Dresden, 01187 Dresden, Germany.ORCID 0000-0001-9373-6751
Katrin TrentzschCenter of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0003-2832-4640
Rocco HaaseCenter of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0003-2465-4909
Marie Luise WeidemannCenter of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.
Robin WeidemannCenter of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0003-4632-1101
Uwe AßmannSoftware Technology Group, Technische Universität Dresden, 01187 Dresden, Germany.ORCID 0000-0002-3513-6448
Tjalf ZiemssenCenter of Clinical Neuroscience, Neurological Clinic, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.ORCID 0000-0001-8799-8202

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical monitoring of walking generates enormous amounts of data that contain extremely valuable information. Therefore, machine learning (ML) has rapidly entered the research arena to analyze and make predictions from large heterogeneous datasets. Such data-driven ML-based applications for various domains become increasingly applicable, and thus their software qualities are taken into focus. This work provides a proof of concept for applying state-of-the-art ML technology to predict the distance travelled of the 2-min walk test, an important neurological measurement which is an indicator of walking endurance. A transparent lean approach was emphasized to optimize the results in an explainable way and simultaneously meet the specified software requirements for a generic approach. It is a general-purpose strategy as a fractional−factorial design benchmark combined with standardized quality metrics based on a minimal technology build and a resulting optimized software prototype. Based on 400 training and 100 validation data, the achieved prediction yielded a relative error of 6.1% distributed over multiple experiments with an optimized configuration. The Adadelta algorithm (LR=0.000814, fModelSpread=5, nModelDepth=6, nepoch=1000) performed as the best model, with 90% of the predictions with an absolute error of <15 m. Factors such as gender, age, disease duration, or use of walking aids showed no effect on the relative error. For multiple sclerosis patients with high walking impairment (EDSS Ambulation Score ≥6), the relative difference was significant (n=30; 24.0%; p<0.050). The results show that it is possible to create a transparently working ML prototype for a given medical use case while meeting certain software qualities.

Indexed as

deep learningfractional factorial design benchmarkinertial measurement unitsmachine learningmultiple sclerosissoftware quality

Identifiers

PMID35743693
PMCPMC9224715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.